Skip to main content

Peer Review reports

From: Impact on decision making framework for medicine purchasing in Chinese public hospital decision-making: determining the value of five dipeptidyl peptidase 4 (DPP-4) inhibitors

Original Submission
8 Jun 2020 Submitted Original manuscript
30 Jun 2020 Author responded Author comments - Yun Bao
Resubmission - Version 2
30 Jun 2020 Submitted Manuscript version 2
12 Jul 2020 Author responded Author comments - Yun Bao
Resubmission - Version 3
12 Jul 2020 Submitted Manuscript version 3
5 Aug 2020 Reviewed Reviewer Report
21 Aug 2020 Reviewed Reviewer Report
7 Oct 2020 Author responded Author comments - Yun Bao
Resubmission - Version 4
7 Oct 2020 Submitted Manuscript version 4
26 Oct 2020 Reviewed Reviewer Report
7 Nov 2020 Reviewed Reviewer Report
20 Nov 2020 Author responded Author comments - Yun Bao
Resubmission - Version 5
20 Nov 2020 Submitted Manuscript version 5
7 Feb 2021 Reviewed Reviewer Report
21 Feb 2021 Author responded Author comments - Yun Bao
Resubmission - Version 6
21 Feb 2021 Submitted Manuscript version 6
14 May 2021 Reviewed Reviewer Report
12 Jul 2021 Author responded Author comments - Yun Bao
Resubmission - Version 7
12 Jul 2021 Submitted Manuscript version 7
25 Jul 2021 Author responded Author comments - Yun Bao
Resubmission - Version 8
25 Jul 2021 Submitted Manuscript version 8
Publishing
27 Jul 2021 Editorially accepted
12 Aug 2021 Article published 10.1186/s12913-021-06827-0

You can find further information about peer review here.

Back to article page